Last reviewed · How we verify
Treatment of moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis
Approved treatments
- Duavee · Pfizer
DUAVEE pairs conjugated estrogens with bazedoxifene, which bind to and activate estrogen receptors α and β.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Treatment of moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis patent landscape — cliff calendar, originator estates, attackable patents
- Treatment of moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis treatment landscape brief
- Treatment of moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis treatment updates RSS
Frequently asked questions about Treatment of moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis
What drugs treat Treatment of moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis?
Tracked treatments include Duavee.
What is the treatment for Treatment of moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis?
Standard treatment for Treatment of moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis includes Duavee. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Treatment of moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis patent cliff · Treatment of moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis CI report
- Treatment: Duavee · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing